INSIGHTS ON PHARMACEUTICAL PACKAGING

PHARMACEUTICAL PACKAGING SOLUTIONS

  • The world is facing a persistent and increasing threat from adulterated prescription drugs. Serialization provides the opportunity to track and trace products from the smallest saleable unit throughout the complete supply chain, and from production site to patients who rely on medication for treatment of diseases.

  • A generic drug must contain the same active ingredients as the original formulation. According to the U.S. Food and Drug Administration (FDA), generic drugs are identical or within an acceptable bioequivalent range to the brand-name counterpart with respect to pharmacokinetic and pharmacodynamic properties.

  • Our global capabilities span a scale of commercial packaging requirements from targeted therapies for select populations including biologics, through to large-scale projects requiring sophisticated technology integration. With true customer focus and flexibility at our core, we are able to adapt to the unique requirements of each global market need including brand and generic ethical pharmaceuticals, biotech medicines, over-the-counter pharmaceuticals, consumer healthcare products, specialized requirements for medical devices and specialty products.

  • Achieve commercial-scale inhalation blister manufacturing with outputs up to 2,400 cavities per minute, flexible powder dosing, and integrated containment options.

  • The pharmaceutical industry continues to bring breakthroughs in the field of new drugs and drug delivery systems amidst the increased scrutiny of the regulators. The packaging acts as the primary sterile barrier in drug delivery systems that safeguard the drug product through its life cycle. The efficiency of the primary sterile barrier and the functional components are of utmost importance to patient safety.